This is a prospective, randomized, open-label, multicenter Phase 3 study evaluating the efficacy and safety of 177Lu-PSMA-I&T versus a switch in standard of care hormone therapy in men with metastatic

Trial overview




A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer


Plantation (Radiation oncology)
350 NW 84th Avenue, Suite 102
Plantation, Florida 33324
(Westside Medical Arts Building)

Boca Raton (Radiation oncology)
3651 FAU Boulevard, Suite 100
Boca Raton, Florida 33431

Troy (Radiation oncology)
4550 Investment Drive, Suite B 111
Troy, Michigan 48098

GenesisCare May Grand Rounds

Update on GenesisCare’s radiopharmaceutical care and research

On May 18th, GenesisCare will be hosting a Global Grand Rounds session on our global theranostics research program, which will include an overview of key active studies in the United States and Australia.

Register for the webinar today